ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14N13436
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Over the Counter OTC Drugs Dietary Supplements Market Research Report 2023
BUY CHAPTERS

Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2030

Code: QYRE-Auto-14N13436
Report
December 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis International AG
Roche Holding AG
Merck& Co. Inc
Sanofi
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline PLC
Bayer Healthcare AG.
Astrazeneca plc
Alacer Corp.
Alcon
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan plc
Reckitt Benckiser Plc
Bausch & Lomb
AbbVie
The Colgate-Palmolive Company

Over the Counter (OTC) Drugs & Dietary Supplements Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Over the Counter (OTC) Drugs & Dietary Supplements Market

Over the Counter (OTC) Drugs & Dietary Supplements Market

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
Market Analysis and Insights: Global Over the Counter (OTC) Drugs & Dietary Supplements Market
The global Over the Counter (OTC) Drugs & Dietary Supplements market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Over the Counter (OTC) Drugs & Dietary Supplements market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Over the Counter (OTC) Drugs & Dietary Supplements, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Over the Counter (OTC) Drugs & Dietary Supplements, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Over the Counter (OTC) Drugs & Dietary Supplements revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Over the Counter (OTC) Drugs & Dietary Supplements market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Over the Counter (OTC) Drugs & Dietary Supplements revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Over the Counter (OTC) Drugs & Dietary Supplements Market Report

Report Metric Details
Report Name Over the Counter (OTC) Drugs & Dietary Supplements Market
CAGR 5%
Segment by Type
  • Analgesic & Pain Relievers
  • Dermatological Products
  • Cough, Cold, and Flu Products
  • Vitamin Supplements
  • Mineral Supplements
  • Ophthalmic Products
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Over the Counter (OTC) Drugs & Dietary Supplements in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over the Counter (OTC) Drugs & Dietary Supplements revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

Ans: The main players in the Over the Counter (OTC) Drugs & Dietary Supplements Market are Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., Alfresa Pharma Corporation, Alkalon A/S, Alliance Healthcare, Allergan, Plc., Reckitt Benckiser Plc., Bausch & Lomb, AbbVie Inc., The Colgate-Palmolive Company

What are the Application segmentation covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

Ans: The Applications covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others

What are the Type segmentation covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report?

Ans: The Types covered in the Over the Counter (OTC) Drugs & Dietary Supplements Market report are Analgesic & Pain Relievers, Dermatological Products, Cough, Cold, and Flu Products, Vitamin Supplements, Mineral Supplements, Ophthalmic Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Analgesic & Pain Relievers
1.2.3 Dermatological Products
1.2.4 Cough, Cold, and Flu Products
1.2.5 Vitamin Supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Market by Application
1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2019-2030)
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
2.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2019-2024)
2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2025-2030)
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Over the Counter (OTC) Drugs & Dietary Supplements by Players
3.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2019-2024)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2019-2024)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio
3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2023
3.5 Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements Head office and Area Served
3.6 Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Product and Application
3.7 Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2019-2024)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2025-2030)
5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2019-2024)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
6.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024)
6.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030)
6.2.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024)
6.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030)
6.3.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
6.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
6.4.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
7.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024)
7.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030)
7.2.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
7.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024)
7.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030)
7.3.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
7.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
7.4.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
8.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
8.2.1 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024)
8.2.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030)
8.2.3 China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
8.3 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
8.3.1 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024)
8.3.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030)
8.3.3 China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
9.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
9.2.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024)
9.2.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030)
9.2.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
9.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
9.3.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024)
9.3.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030)
9.3.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
9.4 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
9.4.1 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024)
9.4.3 Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
10.2.1 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
10.3.1 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
10.4.1 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.1.5 Pfizer Inc. Recent Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.2.5 Novartis International AG Recent Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.3.5 Roche Holding AG Recent Developments
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.4.5 Merck & Co., Inc. Recent Developments
11.5 Sanofi S.A
11.5.1 Sanofi S.A Company Details
11.5.2 Sanofi S.A Business Overview
11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.5.5 Sanofi S.A Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.6.5 Johnson & Johnson Recent Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.7.5 Gilead Sciences Recent Developments
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Details
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.8.5 GlaxoSmithKline plc. Recent Developments
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Company Details
11.9.2 Bayer Healthcare AG Business Overview
11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.9.5 Bayer Healthcare AG Recent Developments
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Company Details
11.10.2 AstraZeneca plc. Business Overview
11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.10.5 AstraZeneca plc. Recent Developments
11.11 Alacer Corp.
11.11.1 Alacer Corp. Company Details
11.11.2 Alacer Corp. Business Overview
11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.11.5 Alacer Corp. Recent Developments
11.12 Alcon Inc.
11.12.1 Alcon Inc. Company Details
11.12.2 Alcon Inc. Business Overview
11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.12.5 Alcon Inc. Recent Developments
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Company Details
11.13.2 Alfresa Pharma Corporation Business Overview
11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.13.5 Alfresa Pharma Corporation Recent Developments
11.14 Alkalon A/S
11.14.1 Alkalon A/S Company Details
11.14.2 Alkalon A/S Business Overview
11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.14.5 Alkalon A/S Recent Developments
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Company Details
11.15.2 Alliance Healthcare Business Overview
11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.15.5 Alliance Healthcare Recent Developments
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Company Details
11.16.2 Allergan, Plc. Business Overview
11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.16.5 Allergan, Plc. Recent Developments
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Company Details
11.17.2 Reckitt Benckiser Plc. Business Overview
11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.17.5 Reckitt Benckiser Plc. Recent Developments
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Company Details
11.18.2 Bausch & Lomb Business Overview
11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.18.5 Bausch & Lomb Recent Developments
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Company Details
11.19.2 AbbVie Inc. Business Overview
11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.19.5 AbbVie Inc. Recent Developments
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Company Details
11.20.2 The Colgate-Palmolive Company Business Overview
11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
11.20.5 The Colgate-Palmolive Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Pfizer Inc
Novartis International AG
Roche Holding AG
Merck& Co. Inc
Sanofi
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline PLC
Bayer Healthcare AG.
Astrazeneca plc
Alacer Corp.
Alcon
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan plc
Reckitt Benckiser Plc
Bausch & Lomb
AbbVie
The Colgate-Palmolive Company
List of Tables
    Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Analgesic & Pain Relievers
    Table 3. Key Players of Dermatological Products
    Table 4. Key Players of Cough, Cold, and Flu Products
    Table 5. Key Players of Vitamin Supplements
    Table 6. Key Players of Mineral Supplements
    Table 7. Key Players of Ophthalmic Products
    Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2019-2024)
    Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2025-2030)
    Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
    Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
    Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
    Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
    Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players (2019-2024)
    Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2023)
    Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Headquarters and Area Served
    Table 24. Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Product and Application
    Table 25. Global Key Players of Over the Counter (OTC) Drugs & Dietary Supplements, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2019-2024)
    Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2025-2030)
    Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2019-2024)
    Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2025-2030)
    Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Over the Counter (OTC) Drugs & Dietary Supplements Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Pfizer Inc. Company Details
    Table 68. Pfizer Inc. Business Overview
    Table 69. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 70. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 71. Pfizer Inc. Recent Developments
    Table 72. Novartis International AG Company Details
    Table 73. Novartis International AG Business Overview
    Table 74. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 75. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 76. Novartis International AG Recent Developments
    Table 77. Roche Holding AG Company Details
    Table 78. Roche Holding AG Business Overview
    Table 79. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 80. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 81. Roche Holding AG Recent Developments
    Table 82. Merck & Co., Inc. Company Details
    Table 83. Merck & Co., Inc. Business Overview
    Table 84. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 85. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 86. Merck & Co., Inc. Recent Developments
    Table 87. Sanofi S.A Company Details
    Table 88. Sanofi S.A Business Overview
    Table 89. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 90. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 91. Sanofi S.A Recent Developments
    Table 92. Johnson & Johnson Company Details
    Table 93. Johnson & Johnson Business Overview
    Table 94. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 95. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 96. Johnson & Johnson Recent Developments
    Table 97. Gilead Sciences Company Details
    Table 98. Gilead Sciences Business Overview
    Table 99. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 100. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 101. Gilead Sciences Recent Developments
    Table 102. GlaxoSmithKline plc. Company Details
    Table 103. GlaxoSmithKline plc. Business Overview
    Table 104. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 105. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 106. GlaxoSmithKline plc. Recent Developments
    Table 107. Bayer Healthcare AG Company Details
    Table 108. Bayer Healthcare AG Business Overview
    Table 109. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 110. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 111. Bayer Healthcare AG Recent Developments
    Table 112. AstraZeneca plc. Company Details
    Table 113. AstraZeneca plc. Business Overview
    Table 114. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 115. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 116. AstraZeneca plc. Recent Developments
    Table 117. Alacer Corp. Company Details
    Table 118. Alacer Corp. Business Overview
    Table 119. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 120. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 121. Alacer Corp. Recent Developments
    Table 122. Alcon Inc. Company Details
    Table 123. Alcon Inc. Business Overview
    Table 124. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 125. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 126. Alcon Inc. Recent Developments
    Table 127. Alfresa Pharma Corporation Company Details
    Table 128. Alfresa Pharma Corporation Business Overview
    Table 129. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 130. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 131. Alfresa Pharma Corporation Recent Developments
    Table 132. Alkalon A/S Company Details
    Table 133. Alkalon A/S Business Overview
    Table 134. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 135. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 136. Alkalon A/S Recent Developments
    Table 137. Alliance Healthcare Company Details
    Table 138. Alliance Healthcare Business Overview
    Table 139. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 140. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 141. Alliance Healthcare Recent Developments
    Table 142. Allergan, Plc. Company Details
    Table 143. Allergan, Plc. Business Overview
    Table 144. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 145. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 146. Allergan, Plc. Recent Developments
    Table 147. Reckitt Benckiser Plc. Company Details
    Table 148. Reckitt Benckiser Plc. Business Overview
    Table 149. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 150. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 151. Reckitt Benckiser Plc. Recent Developments
    Table 152. Bausch & Lomb Company Details
    Table 153. Bausch & Lomb Business Overview
    Table 154. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 155. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 156. Bausch & Lomb Recent Developments
    Table 157. AbbVie Inc. Company Details
    Table 158. AbbVie Inc. Business Overview
    Table 159. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 160. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 161. AbbVie Inc. Recent Developments
    Table 162. The Colgate-Palmolive Company Company Details
    Table 163. The Colgate-Palmolive Company Business Overview
    Table 164. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 165. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024) & (US$ Million)
    Table 166. The Colgate-Palmolive Company Recent Developments
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2023 VS 2030
    Figure 3. Analgesic & Pain Relievers Features
    Figure 4. Dermatological Products Features
    Figure 5. Cough, Cold, and Flu Products Features
    Figure 6. Vitamin Supplements Features
    Figure 7. Mineral Supplements Features
    Figure 8. Ophthalmic Products Features
    Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2023 VS 2030
    Figure 11. Hospital Pharmacies Case Studies
    Figure 12. Retail Pharmacies Case Studies
    Figure 13. Online Pharmacy Case Studies
    Figure 14. Others Case Studies
    Figure 15. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
    Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2023 VS 2030
    Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2023
    Figure 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2023
    Figure 22. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
    Figure 24. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
    Figure 25. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)
    Figure 26. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2019-2030) & (US$ Million)
    Figure 29. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
    Figure 30. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
    Figure 31. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)
    Figure 32. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
    Figure 40. China Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
    Figure 41. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
    Figure 43. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
    Figure 44. Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2019-2030)
    Figure 45. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. China Taiwan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2019-2030)
    Figure 55. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Israel Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. GCC Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 62. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 63. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 64. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 65. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 66. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 67. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 68. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 69. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 70. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 71. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 72. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 73. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 74. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 75. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 76. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 77. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 78. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 79. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 80. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2019-2024)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions